Poster Session - Oncogenes, Growth Factors, and Signal Transducers 2: abstract no. 5266Met is a receptor tyrosine kinase encoded by c-Met proto-oncogene which triggers a wide range of normal physiological signaling cascades upon activation by hepatocyte growth factor (HGF). However, aberrant Met expression and activity are commonly found in human cancers. Emerging evidence has shown the presence of nuclear Met (nMet) in some cancerous tissues and cell lines, suggesting that nMet could have unexplored functions in the nucleus. Met is an attractive therapeutic target for human cancers. Indeed, therapeutic antibodies and inhibitors that antagonize dysregulated Met are currently in clinical trials. However, the classic therapeutic strategies ag...
Complete resection of early-stage non-small cell lung cancer (NSCLC) is potentially curative, yet ap...
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. I...
AbstractInappropriate Met receptor tyrosine kinase signaling can produce proliferative, invasive, an...
Theme: Next Wave in HepatologyAIMS: Met is a receptor tyrosine kinase which triggers a wide range of...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and its burden ...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and its burden ...
Abstract c-Met is a receptor tyrosine kinase belonging to the MET (MNNG HOS transforming gene) famil...
This journal suppl. entitled: Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016...
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. I...
Met is a tyrosine kinase receptor that is considered to be a proto-oncogene. The hepatocyte growth f...
Complete resection of early-stage non-small cell lung cancer (NSCLC) is potentially curative, yet ap...
c-Met, a high-affinity receptor for Hepatocyte Growth Factor (HGF), plays a critical role in tumor g...
c-Met plays a pivotal role in the development and progression of hepatocellular carcinoma (HCC), whi...
Complete resection of early-stage non-small cell lung cancer (NSCLC) is potentially curative, yet ap...
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. I...
AbstractInappropriate Met receptor tyrosine kinase signaling can produce proliferative, invasive, an...
Theme: Next Wave in HepatologyAIMS: Met is a receptor tyrosine kinase which triggers a wide range of...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and its burden ...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and its burden ...
Abstract c-Met is a receptor tyrosine kinase belonging to the MET (MNNG HOS transforming gene) famil...
This journal suppl. entitled: Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016...
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. I...
Met is a tyrosine kinase receptor that is considered to be a proto-oncogene. The hepatocyte growth f...
Complete resection of early-stage non-small cell lung cancer (NSCLC) is potentially curative, yet ap...
c-Met, a high-affinity receptor for Hepatocyte Growth Factor (HGF), plays a critical role in tumor g...
c-Met plays a pivotal role in the development and progression of hepatocellular carcinoma (HCC), whi...
Complete resection of early-stage non-small cell lung cancer (NSCLC) is potentially curative, yet ap...
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. I...
AbstractInappropriate Met receptor tyrosine kinase signaling can produce proliferative, invasive, an...